From ex vivo to in vivo: Shaping the next generation of viral vector manufacturing

Summary

AGC Biologics discusses manufacturing innovations for viral vectors used in in vivo gene delivery therapies, focusing on stable producer lines, purification, and characterization improvements to meet stricter regulatory demands.